Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07658820 · ClinicalTrials.gov registry record · NA

The Role of Carbohydrate Blends and Electrolytes on Physical and Mental Performance During Cycling in the Heat

A NA study, sponsored by Arizona State University.

Not yet
Registry status
NA
Development phase
14
Enrollment target

NCT07658820: Clinical Trial NA study, sponsored by Arizona State University.

NCT07658820 is a NA study that has not yet begun recruiting, run by Arizona State University. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07658820, a NA study, has not yet begun recruiting, sponsored by Arizona State University.

NOT YET RECRUITING
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

The aim of the present study is to evaluate the effectiveness of a milk permeate-based sports drink on hydration, carbohydrate oxidation, exercise performance, vigilance, and reaction time in the heat. We anticipate that the milk permeate, with 44 g per liter and high sodium and potassium, will lead to better hydration, energy delivery, and physical and cognitive performance.

Primary Outcome

cycling performance expressed as time to completion.

Interventions

  • DIETARY_SUPPLEMENT Water (Placebo)
  • DIETARY_SUPPLEMENT Carbohydrate Milk Permeate sports drink
  • DIETARY_SUPPLEMENT 6% Sports drink
  • DIETARY_SUPPLEMENT Low-Carbohydrate Milk Permeate sports drink

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2026-06-22
Est. Completion 2027-12-31
Phase NA
Arizona State University

187 total trials

What is known before NCT07658820 opens enrollment

NCT07658820 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 4 interventions - of which Water (Placebo) is the first listed.

NCT07658820 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07658820 about?

NCT07658820 is a clinical study titled "The Role of Carbohydrate Blends and Electrolytes on Physical and Mental Performance During Cycling in the Heat". The aim of the present study is to evaluate the effectiveness of a milk permeate-based sports drink on hydration, carbohydrate oxidation, exercise performance, vigilance, and reaction time in the heat. We anticipate that the milk permeate, with 44 g per liter and high sodium and potassium, will lead...

What is the current status of trial NCT07658820?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2026-06-22. Estimated completion is 2027-12-31.

What interventions are being tested in trial NCT07658820?

The interventions under investigation include: Water (Placebo) (DIETARY_SUPPLEMENT), Carbohydrate Milk Permeate sports drink (DIETARY_SUPPLEMENT), 6% Sports drink (DIETARY_SUPPLEMENT), Low-Carbohydrate Milk Permeate sports drink (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07658820?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07658820's enrollment target sits among peer trials

14 1909th of 2000 higher than 90 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT07658820, the US trial registry maintained by the National Library of Medicine. NCT07658820 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.